Alpha-1-antitrypsin deficiency is associated with type 2 diabetes [71], and therapy with alpha-1-antitrypsin is already being tested as a treatment strategy for type 1 diabetes [72]. Here, SERPINA1 is linked to hyperinsulinemic hypoglycemia, familial, 4.